Methoxptamine (MXP, 3-MeO-2′-oxo-PCP) is a designer drug of the arylcyclohexylamine class, an analog of PCP with similar effects. Methoxptamine (MXP) has been developed as a drug with a strong antidepressant effect and is an active antagonist of the NMDA receptor, which can cause dissociative visions (hallucinations).

Methoxptamine has a similar chemical structure to PCP.

Methoxptamine (MXP) is a new research chemical and it is legal in many countries for research for scientific purposes in laboratory conditions.

This substance is a designer drug and its toxicological and pharmacological properties are not fully understood.

Methoxptamine (MXP) is a designer drug intended for research and forensic analysis. Methoxptamine (MXP) is produced in modern pharmaceutical laboratory in compliance with all quality standards.

Storage conditions: in a cool and dry place, storage for up to 2 years.